RT
Reliance Trust Portfolio holdings
AUM
$27.5M
Turnover
33.33%
1-Year Est. Return
6.41%
This Fund
S&P 500
This Quarter
Est. Return
+3.62%
1 Year Est. Return
+6.41%
3 Year Est. Return
+32.11%
5 Year Est. Return
+40.7%
10 Year Est. Return
–
AUM
$85.9M
AUM Growth
-$745K
(-0.86%)
Cap. Flow
-$3.13M
Cap. Flow
% of AUM
-3.65%
Top 10 Holdings %
Top 10 Hldgs %
23.7%
Holding
157
New
16
Increased
44
Reduced
66
Closed
12
Avg Time Held
1.2
years
Top 10 Avg Time Held
1
year
Top 20 Avg Time Held
1
year
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
WisdomTree True Developed International Fund
DOL
|
+$654K |
| 2 |
WisdomTree US MidCap Dividend Fund
DON
|
+$552K |
| 3 |
SPDR Gold Trust
GLD
|
+$431K |
| 4 |
Vanguard High Dividend Yield ETF
VYM
|
+$365K |
| 5 |
Las Vegas Sands
LVS
|
+$280K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard FTSE All-World ex-US ETF
VEU
|
+$780K |
| 2 |
Vanguard Morningstar Mega Cap Growth ETF
MGK
|
+$763K |
| 3 |
Vanguard Morningstar Mega Cap Value ETF
MGV
|
+$598K |
| 4 |
Vanguard Morningstar Mid-Cap Growth ETF
VOT
|
+$402K |
| 5 |
Vanguard Intermediate-Term Bond ETF
BIV
|
+$348K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 20.02% |
| 2 | Consumer Staples | 14.81% |
| 3 | Financials | 13.1% |
| 4 | Healthcare | 11.71% |
| 5 | Technology | 9.59% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
51
Pfizer
PFE
$167B
| $514K | 0.6% |
17,414
-1,173
| -6% | -$33.6K |
2013 Q2
6 quarters
|
|
52
Abbott
ABT
$177B
| $508K | 0.59% |
11,276
-416
| -4% | -$18.1K |
2014 Q3
1 quarter
|
|
53
Colgate-Palmolive
CL
$73.3B
| $507K | 0.59% |
7,328
| – | – |
2013 Q2
6 quarters
|
|
54
Berkshire Hathaway Class B
BRK.B
$1.12T
| $504K | 0.59% |
3,355
-150
| -4% | -$21.7K |
2013 Q2
6 quarters
|
|
55
Gilead Sciences
GILD
$190B
| $500K | 0.58% |
5,300
+1,013
| +24% | +$105K |
2013 Q4
4 quarters
|
|
56
Teva Pharmaceutical Industries Limited
TEVA
$48.2B
| $485K | 0.56% |
8,439
-206
| -2% | -$11.5K |
2013 Q2
6 quarters
|
|
57
Vanguard Real Estate ETF
VNQ
$36.3B
| $457K | 0.53% |
5,642
+1,416
| +34% | +$111K |
2013 Q2
6 quarters
|
|
58
Boeing
BA
$145B
| $447K | 0.52% |
3,446
-123
| -3% | -$15.6K |
2013 Q2
6 quarters
|
|
59
RTX Corp
RTX
$251B
| $441K | 0.51% |
6,099
-65
| -1% | -$4.43K |
2013 Q2
6 quarters
|
|
60
Bristol-Myers Squibb
BMY
$121B
| $431K | 0.5% |
7,300
-1,711
| -19% | -$96.5K |
2013 Q2
6 quarters
|
|
61
CVS Health
CVS
$115B
| $428K | 0.5% |
4,445
+155
| +4% | +$13.7K |
2013 Q2
6 quarters
|
|
|
62
SPDR Gold Trust
GLD
$139B
| $424K | 0.49% |
+3,733
| New | +$431K |
2014 Q4
0 quarters
|
|
63
Vanguard Morningstar Small-Cap Value ETF
VBR
$35.4B
| $417K | 0.49% |
3,938
-1,231
| -24% | -$127K |
2013 Q2
6 quarters
|
|
64
Stryker
SYK
$107B
| $411K | 0.48% |
4,359
-35
| -0.8% | -$3.1K |
2013 Q2
6 quarters
|
|
|
ESRX
65
DELISTED
Express Scripts Holding Company
ESRX
| $411K | 0.48% |
4,858
+53
| +1% | +$4.14K |
2013 Q2
6 quarters
|
|
66
PIMCO 0-5 Year High Yield Corporate Bond Index Exchange-Traded Fund
HYS
$1.67B
| $409K | 0.48% |
4,057
-96
| -2% | -$9.9K |
2013 Q2
6 quarters
|
|
67
MetLife
MET
$63B
| $409K | 0.48% |
8,491
-391
| -4% | -$18.6K |
2013 Q2
6 quarters
|
|
68
Vanguard Total Bond Market
BND
$162B
| $406K | 0.47% |
4,931
| – | – |
2013 Q2
6 quarters
|
|
69
HP
HPQ
$27.2B
| $400K | 0.47% |
21,983
| – | – |
2013 Q2
6 quarters
|
|
70
State Street SPDR S&P Dividend ETF
SDY
$21.1B
| $392K | 0.46% |
4,969
| – | – |
2013 Q2
6 quarters
|
|
71
Oracle
ORCL
$394B
| $390K | 0.45% |
8,676
+93
| +1% | +$3.79K |
2013 Q2
6 quarters
|
|
72
Healthpeak Properties
DOC
$12.9B
| $388K | 0.45% |
9,669
+1,102
| +13% | +$43.7K |
2013 Q2
6 quarters
|
|
73
American Express
AXP
$206B
| $386K | 0.45% |
4,149
+166
| +4% | +$14.9K |
2013 Q2
6 quarters
|
|
74
Cisco
CSCO
$449B
| $384K | 0.45% |
13,834
+3,792
| +38% | +$97.9K |
2013 Q2
6 quarters
|
|
75
Enterprise Products Partners
EPD
$77.5B
| $379K | 0.44% |
10,492
| – | – |
2013 Q2
6 quarters
|
|
Similar funds
PIA
FCG
RCP
MP
MAU
JRWL
CPA
AGU
Reliance Trust's Q4 2014 Portfolio in Review
As of Q4 2014, Reliance Trust held 157 positions worth $85.9M, down 0.86% from $86.6M the previous quarter. Its ten largest holdings account for 24% of the portfolio.
Reliance Trust withdrew a net $3.13M in Q4 2014, closing 12 positions and reducing 66 holdings. Its most notable exit was State Street SPDR Bloomberg Short Term High Yield Bond ETF, an estimated $333K position sold in full.
By sector, the portfolio is most concentrated in Miscellaneous at 20% of assets, down from 23% a quarter earlier, followed by Consumer Staples and Financials.
Against the trend, Reliance Trust opened a new position in WisdomTree True Developed International Fund worth $630K.
- Reliance Trust's largest Q4 2014 buy was WisdomTree True Developed International Fund: 13,492 shares worth $630K.
- Reliance Trust added most to Vanguard Real Estate ETF in Q4 2014, an estimated $111K increase.
- Reliance Trust's biggest Q4 2014 reduction was Vanguard FTSE All-World ex-US ETF, cutting an estimated $780K.
- Reliance Trust fully exited State Street SPDR Bloomberg Short Term High Yield Bond ETF in Q4 2014, selling an estimated $333K.
- Reliance Trust's ten largest holdings make up 24% of its $85.9M portfolio in Q4 2014.
- Reliance Trust opened 16 new positions and closed 12 in Q4 2014.
- Reliance Trust's portfolio value fell 0.86% quarter-over-quarter to $85.9M.
Based on Reliance Trust's 13F filing for Q4 2014, filed 6 Feb 2015.